Effect of a Low-calorie and High-protein Diet Specially Rich in Animal Protein Compared to a Low-calorie and High-protein Diet Specially Rich in Plant Protein on Glucose Metabolism in Subjects With Prediabetes or Type 2 Diabetes and Overweight or Obesity.
A Randomized Study to Investigate the Effect of a Low-calorie and High-protein Diet Specially Rich in Animal Protein Compared to a Low-calorie and High-protein Diet Specially Rich in Plant Protein on Glucose Metabolism in Subjects With Prediabetes or Type 2 Diabetes and Overweight or Obesity.
1 other identifier
interventional
120
1 country
1
Brief Summary
The aim of the study is to explore the effect of a low-calorie diet rich in protein (with a content of 35% of the total calories of the diet), mostly coming from animal sources (75% of total protein), compared to a hypocaloric diet rich in protein (with a content of 35% of the total calories of the diet), mostly coming from plant sources (75% of total proteins), in subjects with prediabetes or type 2 diabetes and overweight or obesity, on body composition, glucose and lipid metabolisms, after 6 months of intervention. To achieve the objective, a nutritional intervention study is carried out by randomizing participants to: a) a hypocaloric and high-protein diet (35% of total calories), mostly of them coming from animal sources (75% of total protein); b) a hypocaloric and high-protein diet (35% of total calories), mostly of them coming from plant sources (75% of total protein). The study has a total duration of 6 months and include the assessment of clinical, anthropometric, biochemical and lifestyle parameters, at the beginning of the study and after 3 and 6 months of intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable diabetes-mellitus-type-2
Started Jul 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2021
CompletedFirst Submitted
Initial submission to the registry
July 1, 2022
CompletedFirst Posted
Study publicly available on registry
July 13, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2022
CompletedNovember 8, 2022
November 1, 2022
1.3 years
July 1, 2022
November 6, 2022
Conditions
Outcome Measures
Primary Outcomes (7)
Glucose change.
Glucose change assessed by difference in fasting glucose concentration (mg/dL and %) comparing 3 and 6 months visits with respect to baseline.
After 3 and 6 months of intervention.
Glycated hemoglobin change.
Glycated hemoglobin change assessed by difference in glycated hemoglobin concentration (%) comparing 3 and 6 months visits with respect to baseline.
After 3 and 6 months of intervention.
Insulin change.
Insulin change assessed by difference in fasting insulin concentration (UI/mL and %) comparing 3 and 6 months visits with respect to baseline.
After 3 and 6 months of intervention.
HOMA-IR change.
HOMA-IR change assessed by difference in HOMA-IR concentration (absolute units and %) comparing 3 and 6 months visits with respect to baseline. HOMA-IR is calculated by calculating: \[(fasting glucose (mg/dL) x 0,0555) x fasting insulin (UI/ml)\] ÷ 22,5.
After 3 and 6 months of intervention.
Body fat mass change.
Body fat mass change assessed by difference in fat mass (%) comparing 3 and 6 months visits with respect to baseline.
After 3 and 6 months of intervention.
Fat-free mass change.
Fat-free mass change assessed by difference in fat free-mass (%) comparing 3 and 6 months visits with respect to baseline.
After 3 and 6 months of intervention.
Visceral fat mass change.
Visceral fat mass change assessed by difference in visceral fat mass (kg and %) comparing 3 and 6 months visits with respect to baseline.
After 3 and 6 months of intervention.
Secondary Outcomes (4)
Total cholesterol change.
After 3 and 6 months of intervention.
LDL cholesterol change.
After 3 and 6 months of intervention.
HDL cholesterol change.
After 3 and 6 months of intervention.
Triglycerides change.
After 3 and 6 months of intervention.
Other Outcomes (9)
C-reactive protein change.
After 3 and 6 months of intervention.
Liver enzymes change.
After 3 and 6 months of intervention.
Uric acid change.
After 3 and 6 months of intervention.
- +6 more other outcomes
Study Arms (2)
High-protein animal diet.
EXPERIMENTALLow-calorie and high-protein diet (35% of total calories), mostly of protein coming from animal sources (75% of total protein).
High-protein vegetal diet.
EXPERIMENTALLow-calorie and high-protein diet (35% of total calories), mostly of protein coming from plant sources (75% of total protein).
Interventions
Diet was prescribed to the participant and menus and recipes were also provided.
Diet was prescribed to the participant and menus and recipes were also provided.
Eligibility Criteria
You may qualify if:
- Aged between 18 and 80.
- BMI between 27.5 kg/m2 and 40 kg/m2.
- Diagnosed as prediabetes or type 2 diabetes according to ADA criteria.
- Informed consent to be signed.
You may not qualify if:
- Taking antidiabetic drugs (except for metformin with stable dose in the previous 6 months).
- Taking lipid-lowering drugs in unstable dose in the previous 2 months.
- Taking functional foods (i.e. sterols enriched food) or any other dietary supplement with a significant effect on lipid and glucose metabolism and body weight.
- Uncontrolled type 2 diabetes (i.e. glycated hemoglobin over 8%)
- Any disease that could affect study results (i.e. uncontrolled hypothyroidism).
- Alcohol intake over 30 g/day.
- Pregnancy or breastfeeding.
- Any other condition that investigators consider that could interfere with study outcomes.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Instituto de Investigación Sanitaria Aragón, Hospital Universitario Miguel Servet, Universidad de Zaragoza
Zaragoza, 50009, Spain
Related Publications (1)
Rodrigo-Carbo C, Madinaveitia-Nisarre L, Perez-Calahorra S, Gracia-Rubio I, Cebollada A, Galindo-Lalana C, Mateo-Gallego R, Lamiquiz-Moneo I. Low-calorie, high-protein diets, regardless of protein source, improve glucose metabolism and cardiometabolic profiles in subjects with prediabetes or type 2 diabetes and overweight or obesity. Diabetes Obes Metab. 2025 Jan;27(1):268-279. doi: 10.1111/dom.16013. Epub 2024 Oct 17.
PMID: 39420528DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
July 1, 2022
First Posted
July 13, 2022
Study Start
July 1, 2021
Primary Completion
October 1, 2022
Study Completion
November 1, 2022
Last Updated
November 8, 2022
Record last verified: 2022-11
Data Sharing
- IPD Sharing
- Will not share